Camilla Soenderby

Camilla Soenderby

Director/Board Member at BB BIOTECH AG

Net worth: - $ as of 30/06/2026

54 year
Health Technology
Distribution Services
Finance

Profile

Camilla Soenderby is currently Director at Affibody Medical AB, Non-Executive Director at F2G Ltd. since 2021, Director at BB Biotech AG since 2024, Independent Director at Abivax SA since 2024, and Independent Director at Inventiva SA starting in 2026.
Former roles include Head-Product Strategy Officer at Takeda Pharmaceutical Co., Ltd. from 2019 to 2020, Head-Global Product Strategy at Shire France SAS, General Manager at Schering-Plough Ltd. (Taiwan), and General Manager at AbbVie SAS (France).
Education includes undergraduate studies at the University of Copenhagen.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
28/02/2026 0 ( -.--% ) - $ 30/06/2026

Camilla Soenderby active positions

CompaniesPositionStart
BB BIOTECH AG Director/Board Member 21/03/2024
ABIVAX Director/Board Member 02/04/2024
INVENTIVA Director/Board Member 30/06/2026
Director/Board Member 15/09/2021
Director/Board Member -

Former positions of Camilla Soenderby

CompaniesPositionEnd
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal 01/01/2020
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Camilla Soenderby's experience

Training of Camilla Soenderby

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

28

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Distribution Services

  1. Stock Market
  2. Insiders
  3. Camilla Soenderby